entity

TFEB activation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TFEB activation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections

9Hypotheses

9Analyses

8Outgoing

8Incoming

0Experiments

9Debates

No AI portrait yet

Outgoing (8)

Target	Relation	Type	Str
Alzheimer's disease	protects_against	disease	0.70
tau pathology	prevents	phenotype	0.70
neurodegeneration	associated_with	disease	0.70
alpha-synuclein clearance	enhances	phenotype	0.70
GBA enzyme function	associated_with	protein	0.70
GBA-synuclein pathological loop	associated_with	phenotype	0.70
alpha-synuclein aggregate clearance	promotes	mechanism	0.70
neurodegeneration	protective_against	phenotype	0.70

Incoming (8)

Source	Relation	Type	Str
trehalose	activates	drug	0.90
30654731	preceded	paper	0.90
lysosomal dysfunction	causes (dysfunction precedes and triggers compensatory TFE)	mechanism	0.75
Lysosomal dysfunction	causes	phenotype	0.70
lysosomal acidification	regulates	pathway	0.70
trehalose-induced lysosomal permeabilization	causes	phenotype	0.70
Proteostatic stress	causes	phenotype	0.70
mTORC1 inhibition	activates	mechanism	0.70

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TFEB Activation to Restore Lysosomal Biogenesis in Aged Syna	0.591	proteomics	Quantitative proteomics of the aging syn
Synergistic enhancement of autophagy and lysosomal biogenesi	0.565	neuroscience	Lysosomal dysfunction and cathepsin leak
TFEB Activation Clears Tau-Loaded Endolysosomal Compartments	0.560	neurodegeneration	Investigate prion-like spreading of tau
TFEB Activation to Restore Lysosomal Biogenesis in Alzheimer	0.523	proteomics	Quantitative proteomics of the aging syn
Parallel Multi-Pathway Convergence on TFEB Activation	0.450	neurodegeneration	Why do structurally diverse sugars (treh

TFEB Activation to Restore Lysosomal Function in Parkinson's	0.380	proteomics	Quantitative proteomics of the aging syn
TFEB Activation to Restore Lysosomal Biogenesis in Parkinson	0.380	proteomics	Quantitative proteomics of the aging syn
Combinatorial TFEB Activation and Anti-Inflammatory Therapy	0.000	-	GBA-Synuclein Loop: Therapeutic Strategi
Autophagy Enhancement via TFEB Activation	0.000	-	Selective vulnerability of entorhinal co

Mentioning Analyses (9)

Scientific analyses that reference this entity

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

neurodegeneration | 2026-04-16 | 0 hypotheses

What validated biomarkers can determine optimal TFEB activity windows during dis

neurodegeneration | 2026-04-11 | 0 hypotheses

Does TFEB dysfunction causally drive neurodegeneration or represent compensatory

molecular biology | 2026-04-10 | 0 hypotheses

Why do structurally diverse sugars (trehalose, melibiose, lactulose) produce ide

neurodegeneration | 2026-04-08 | 3 hypotheses Top: 0.470

What determines the specificity of calcium-dependent PPP3/calcineurin activation

neurodegeneration | 2026-04-07 | 4 hypotheses Top: 0.705

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (9)

Multi-agent debates referencing this entity

While DNAJB1 enhancement showed promise, the debate raised concerns about whethe

closed · Rounds: 4 · Score: 0.73 · 2026-04-22

The study shows trehalose causes lysosomal membrane permeabilization (LMP) that

closed · Rounds: 4 · Score: 0.61 · 2026-04-21

While the study establishes that trehalose-induced lysosomal permeabilization ac

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

The finding that trehalase-resistant analogs and other disaccharides mimic treha

closed · Rounds: 4 · Score: 0.60 · 2026-04-21

The core causation versus correlation debate remains unresolved despite being ce

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate proposed temporal TFEB modulation but identified no validated biomark

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

While RGS6 deficiency causes Parkinson's-like pathology, whether enhancing RGS6

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?

closed · Rounds: 4 · Score: 0.89 · 2026-04-10

The debate highlighted TFEB's role in mitochondrial-lysosomal coupling but could

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning TFEB activation in their description or question text

TFEB Activation to Restore Lysosomal Function in Parkinson's Disease Alpha-Synuc

Score: 0.380 · proteomics · 2026-04-27

Parkinson's disease is characterized by the accumulation of misfolded alpha-synuclein protein aggregates (Lewy bodies) i

TFEB Activation to Restore Lysosomal Biogenesis in Parkinson's Disease Dopaminer